Report forecast the global flow diversion aneurysm treatment
market to grow at a CAGR of 14.55% during the period 2016-2020.
The global flow diversion aneurysm treatment market is
driven by several factors that include the increase in the incidence of brain
aneurysm, increase in demand for minimally invasive endovascular surgeries, and
advances in technology. However, challenges such as risk of complications in
cerebrovascular/neurovascular procedures, stringent regulations for the
approval of devices, the high cost of flow diversion aneurysm treatment, and
the increase in competition among vendors restrain the market growth.
The report covers the present scenario and the growth
prospects of the global flow diversion aneurysm treatment market for 2016-2020.
To calculate the market size, we consider the revenue generated from the sales
of flow diversion aneurysm devices to hospitals and ambulatory surgical centers
(ASCs).
The market is divided into the following segments based
on geography:
- Americas
- APAC
- EMEA
According to the report, increase in demand for minimally
invasive endovascular surgeries will be a key driver for market growth.
Minimally invasive endovascular surgeries reduce the duration of hospital stay,
allowing a patient to recover faster, and this also translates into better
utilization of healthcare resources at a lower cost. In addition, as these
surgeries are performed with minute incisions in the body to treat blockages in
arteries they do not leave any visible scars. The neuro-endovascular coiling
surgeries are conducted by using a minimally invasive endovascular technique.
These procedures are possible even in individuals with high risk of aneurysm
rupture. Also, these surgeries can be carried out in ASCs. These advantages are
expected to increase the demand for these procedures and contribute to market
growth during the forecast period.
Further, the report states that inadequate clinical evidence
will be a challenge for the market. Currently, the availability of flow
diversion aneurysm treatment devices in the market is limited because of the
lack of clinical data supporting the safety and efficacy of these devices. Flow
diversion aneurysm treatment is a high-risk procedure. The procedures to treat
intracranial aneurysm are complex and need microsurgical techniques to achieve
favorable outcomes. Studies like the International Study of unruptured
Intracranial Aneurysms (ISUIA) have suggested new guidelines for clinical trials
based on the stability, performance, treatment, and delayed response of flow
diversion devices. Researchers are focusing on conducting advanced clinical
studies with an eye toward safety and efficacy during the process of
manufacturing; there is a need to comply with good manufacturing practices and
regulation standards for approvals. Such issues lead to the lack of clinical
evidence that will hamper the adoption rates of flow diversion aneurysm
treatment devices.
Global Flow Diversion Aneurysm Treatment Market 2016-2020,
has been prepared based on an in-depth market analysis with inputs from
industry experts. The report covers the market landscape and its growth
prospects over the coming years. The report also includes a discussion of the
key vendors operating in this market.
key players in the global flow diversion aneurysm treatment
market: Balt Extrusion, Medtronic,
MicroVention, and Stryker.
Other Prominent Vendors in the market are: Acandis,
InspireMD, and Phenox.
Market driver
- Increase in instances of brain aneurysm caused by cerebral disorders
- For a full, detailed list, view our report
Market challenge
- Complications associated with cerebrovascular/neurovascular procedures
- For a full, detailed list, view our report
Market trend
- Product approvals and tentative investigational product launches
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Spanning over 72 pages and 42 Exhibit “Global
Flow Dimension Aneurysm Treatment Market 2016 - 2020” report covers Executive
summary, Scope of the report, Market research methodology, Introduction, Market
landscape, Introduction, Ongoing clinical trials and approved indications for
flow diverters, Evolution of endovascular aneurysm treatment, Geographical
segmentation, Buying criteria, Market drivers, Impact of drivers, Market
challenges, Impact of drivers and challenges, Market trends, Vendor landscape,
Key vendor analysis, Appendix.
For
more information Visit at: http://mrr.cm/J9r
Related Reports;
Global
Pain Management Drugs Market 2016-2020 - Visit at - http://mrr.cm/J9H
Global
Spinal Cord Stimulation Devices Market 2016-2020 - Visit at - http://mrr.cm/J9V
Global
Biosimilars Market 2016-2020 - Visit at - http://mrr.cm/J9j
Global
Pneumococcal Vaccine Market 2016-2020 - Visit at - http://mrr.cm/J99
No comments:
Post a Comment
Note: only a member of this blog may post a comment.